Physician profile
Patrick C Dickerson
NPI 1467718619
$46,619.70
in general payments reported to CMS, 2019-2025
10 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $1,436 · 2021: $3,242 · 2022: $5,425 · 2023: $985 · 2024: $5,167 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,291 · Food and Beverage: $1,995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,290.58 |
| Food and Beverage | $1,994.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $25,312.39 | 2019-2023 | Shoulder Implants Fibertak Knotless |
| Zimmer Biomet Holdings, INC. | $7,343.64 | 2019-2024 | Persona, Rosa |
| Midsouth Orthopedics INC. | $5,357.34 | 2019-2024 | |
| Smith+Nephew, INC. | $4,605.73 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Novostitch |
| Djo, LLC | $2,187.50 | 2019 | |
| Stryker Corporation | $1,517.34 | 2019-2024 | Blueprint Patient Specific Instrumentation, Mako, Gamma |
| Depuy Synthes Sales INC. | $130.53 | 2023-2025 | Attune, Actis, Tfn-Advance |
| Peerless Surgical INC. | $94.42 | 2019 | |
| Medical Device Business Services, INC. | $53.73 | 2024-2025 | Attune |
| Pacira Pharmaceuticals Incorporated | $17.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Dickerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.